The Economic Burden of Glaucoma and Ocular Hypertension
- 1 January 2005
- journal article
- review article
- Published by Springer Nature in Drugs & Aging
- Vol. 22 (4) , 315-321
- https://doi.org/10.2165/00002512-200522040-00004
Abstract
This paper reviews the burden and economic consequences of glaucoma upon healthcare systems and patients, especially elderly patients. An extensive review of the literature was conducted, primarily...Keywords
This publication has 37 references indexed in Scilit:
- Blindness, low vision, and other handicaps as risk factors attached to institutional residenceBritish Journal of Ophthalmology, 2004
- PAE12 TREATMENT DURATION AS A COST DRIVER OF GLAUCOMA CARE: A LIFE-LONG SOCIETAL PERSPECTIVE IN FRANCE, GERMANY AND THE NETHERLANDValue in Health, 2003
- Cost and effectiveness of brinzolamide versus dorzolamide in current practice: an analysis based on the UK-GPRD databaseJournal of Medical Economics, 2003
- Cost-Minimisation Study of Dorzolamide versus Brinzolamide in the Treatment of Ocular Hypertension and Primary Open-Angle GlaucomaPharmacoEconomics, 2003
- The effects of new topical treatments on management of glaucoma in Scotland: an examination of ophthalmological health careBritish Journal of Ophthalmology, 2002
- Resource Use and Costs of Patients With Glaucoma or Ocular Hypertension: A One-year Study Based on Retrospective Chart Review in the NetherlandsJournal of Glaucoma, 2001
- Utility of predictive equations for estimating the prevalence and incidence of primary open angle glaucoma in the UKBritish Journal of Ophthalmology, 2000
- Number of people with glaucoma worldwide.British Journal of Ophthalmology, 1996
- The Economic Burden of Glaucoma in the UKPharmacoEconomics, 1995
- Cost analysis of early trabeculectomy versus conventional management in primary open angle glaucomaEye, 1991